BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Peucedanol | Peucedanol is an intriguing biologically active constituent originating from the diverse Peucedanum plants, aiding in studying inflammation encompassing rheumatoid arthritand asthma. Group: Pharmaceutical. CAS No. 20516-23-8. Pack Sizes: 1 mg. Product ID: NP1076. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Pevonedistat | Pevonedistat, also known as MLN-4924 and TAK-924, is a small molecule inhibitor of Nedd8 activating enzyme (NAE) with potential antineoplastic activity. Uses: Enzyme inhibitors. Group: Pharmaceutical. CAS No. 905579-51-3. Pack Sizes: 10 mg. Product ID: B2693-263059. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pexidartinib hydrochloride | Pexidartinib is an oral, potent mutil-targeted receptor tyrosine kinase inhibitor of CSF-1R with IC50 of 20 nM, Kit with IC50 of 10 nM, and Flt3 with IC50 160 nM. Group: Pharmaceutical. CAS No. 2040295-03-0. Pack Sizes: 250 mg. Product ID: B1370-427893. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pexidartinib (PLX3397) | Pexidartinib (PLX3397) is an oral, potent mutil-targeted receptor tyrosine kinase inhibitor of CSF-1R with IC50 of 20 nM, Kit with IC50 of 10 nM, and Flt3 with IC50 160 nM. Phase 3, respectively. Group: Pharmaceutical. CAS No. 1029044-16-3. Pack Sizes: 200 mg. Product ID: B0084-470807. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pexiganan acetate | An antimicrobial peptide (AMP) that is effective against a broad spectrum of bacteria including aerobic and anaerobic, gram-positive and gram-negative. Group: Pharmaceutical. CAS No. 172820-23-4. Pack Sizes: 5 mg. Product ID: BAT-010095. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pexmetinib | Pexmetinib (ARRY-614) is a potent, orally bioavailable, dual p38 MAPK/Tie-2 inhibitor with IC50 of 4 nM/18 nM in a HEK-293 cell line. It has potential antineoplastic, anti-inflammatory, and antiangiogenic activities. It inhibits other kinases including vascular endothelial growth factor receptor (VEGFR2) and Src tyrosine kinases. Group: Pharmaceutical. CAS No. 945614-12-0. Pack Sizes: 50 mg. Product ID: B2693-470949. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-04418948 | PF-04418948 is a potent and selective prostaglandin EP2 receptor antagonist with IC50 of 16 nM. Phase 1. PF-04418948 antagonizes the effects of butaprost and PGE2 on an EFS-induced contraction of the human myometrium, and antagonizes PGE2-induced relaxation of carbachol pre-contracted rings of mouse trachea. Group: Pharmaceutical. CAS No. 1078166-57-0. Pack Sizes: 50 mg. Product ID: B2693-470809. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-04457845 | PF-04457845 is a potent and exquisitely selective inhibitor of FAAH, with an IC50 of 7.2 nM, and both analgesic and antiinflammatory effects in animal studies comparable to naproxen. Group: Pharmaceutical. CAS No. 1020315-31-4. Pack Sizes: 100 mg. Product ID: B2693-456459. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-04691502 | PF-04691502 is an agent targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. It inhibits both PI3K and mTOR kinases, which may result in apoptosis and growth inhibition of cancer cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy. mTOR, a serine/threonine kinase downstream of PI3K, may also be activated independent of PI3K. Group: Pharmaceutical. CAS No. 1013101-36-4. Pack Sizes: 50 mg. Product ID: B0084-456382. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-06282999 | PF-06282999 is a selective myeloperoxidase Inhibitor originate by Pfizer. It showed good oral pharmacokinetics in preclinical species and robust irreversible inhibition of plasma MPO activity. In Mar 2015, Pfizer terminated phase I trial for the treatment of Acute coronary syndromes in Healthy volunteers in USA. Uses: Acute coronary syndromes. Group: Pharmaceutical. CAS No. 1435467-37-0. Pack Sizes: 10 mg. Product ID: B0084-474817. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF 06409577 | PF 06409577 is a potent and selective allosteric activator of AMPK (EC50 values are 7 and >40000 nM for AMPKα1β1γ1 and AMPKα1β2γ1, respectively) for the potential treatment of diabetic nephropathy. PF-06409577 showed efficacy in a preclinical model of diabetic nephropathy. Group: Pharmaceutical. CAS No. 1467057-23-3. Pack Sizes: 100 mg. Product ID: B2693-170035. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-06650833 | PF-06650833 is an inhibitor of Interleukin-1 receptor associated kinase 4 (IRAK4), which is an omnipresently expressed serine/threonine kinase involved in the regulation of innate immunity. PF-06650833 is useful for the treatment of autoimmune and inflammatory diseases associated with lnterleukin-1 Receptor Associated Kinase (IRAK) and more particularly modulates the function of IRAK. It is undergoing testing in a Phase II clinical study. Group: Pharmaceutical. CAS No. 1817626-54-2. Pack Sizes: 25 mg. Product ID: B0084-474124. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-06651600 | PF-06651600 is a selective JAK3 inhibitor with IC50 value of 0.346 nM. It was shown to inhibit Th1 and Th17 cell differentiation and function in vitro. Group: Pharmaceutical. CAS No. 1792180-81-4. Pack Sizes: 100 mg. Product ID: B2693-286108. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-07321332 | PF-07321332 is an orally available SARS-CoV 3C-like protease (3CLPRO) inhibitor. 3C-like protease (3CLPRO) is the main protease found in coronaviruses, which cleaves the coronavirus polyprotein at eleven conserved sites. PF-07321332 has demonstrated oral activity in a mouse-adapted SARS-CoV-2 model and has achieved oral plasma concentrations exceeding the in vitro antiviral cell potency in a phase I clinical trial in healthy human participants. Group: Pharmaceutical. CAS No. 2628280-40-8. Pack Sizes: 100 mg. Product ID: B2693-074195. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-1355 | PF-1355 is a selective, mechanism-based inhibitor of myeloperoxidase (MPO) (IC50 = 1.5 μM in LPS-stimulated human whole blood) with excellent selectivity for MPO without disrupting a panel of 50 receptors, enzymes, ion channels and transporters, including thyroid peroxidase. PF-1355 was used to test the hypothesis that MPO activity is a critical mediator of disease activity in immune complex vasculitis mouse models, and to support the confidence in rationale for this mechanism as a therapeutic approach to treat related human condition such as alleviating tissue injury caused by Goodpasture syndrome and pulmonary vasculitis induced by immune complexes. Group: Pharmaceutical. CAS No. 1435467-38-1. Pack Sizes: 50 mg. Product ID: B0084-474818. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-3084014 | PF-3084014 is a selective γ-secretase inhibitor (IC50 = 6.2 nM in a cell-free assay). It has been shown to inhibit self-renewal and proliferation of cancer stem cells. Group: Pharmaceutical. CAS No. 1290543-63-3. Pack Sizes: 50 mg. Product ID: B1370-286393. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-4136309 | PF-4136309 is a potent, selective, and orally bioavailable antagonist of CCR2, a chemokine receptor of the super family of seven-transmembrane G-protein-coupled receptors (GPCRs). Group: Pharmaceutical. CAS No. 1341224-83-6. Pack Sizes: 100 mg. Product ID: B2693-457930. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF 429242 dihydrochloride | PF 429242 is a reversible and competitive inhibitor of sterol regulatory element-binding protein (SREBP) site 1 protease (IC50 = 0.175 μM), a transcriptional regulators of cholesterol, fatty acid, and glucose metabolism. It reduces hepatic synthesis of cholesterol and fatty acid in mice. Group: Pharmaceutical. CAS No. 2248666-66-0. Pack Sizes: 100 mg. Product ID: B1370-291470. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-431396 | PF-431396 is a dual focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (PYK2) inhibitor (IC50 values are 2 and 11 nM respectively). Group: Pharmaceutical. CAS No. 717906-29-1. Pack Sizes: 100 mg. Product ID: B2693-194496. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pf-4708671 Impurities | Pf-4708671 Impurities hold crucial significance within the biomedical sector due to their integral function in quality assurance and safety evaluation during Pf-4708671 synthesis. As a selective S6K1 inhibitor, it facilitates profound exploration of cellular signaling pathways, prominently in oncological and metabolic research, thereby advancing pharmacological innovation. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-5190457 | PF-5190457 is a selective Growth hormone secretagogue receptor inverse agonist and it can increase insulin secretion in glucose-stimulated human islets. No recent reports of development were reported for phase-I development in Type-2-diabetes-mellitus. Uses: Type 2 diabetes mellitus. Group: Pharmaceutical. CAS No. 1334782-79-4. Pack Sizes: 500 mg. Product ID: B2693-475313. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-562271 | PF-562271 is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs. Group: Pharmaceutical. CAS No. 717907-75-0. Pack Sizes: 50 mg. Product ID: B2693-194471. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-670462 | PF-670462 is a potent and selective inhibitor of CK1ε in isolated enzyme preparations. It inhibits PER protein nuclear translocation causing phase shifts in circadian rhythms and attenuates methamphetamine-stimulated locomotion in vivo. It less effectively inhibits a wide variety of related or common kinases. It disrupts circadian rhythms in cells and animals and blocks the locomotor response to amphetamines in mice. It remains unclear whether one of the kinases has a predominant role in regulating the circadian clock. Group: Pharmaceutical. CAS No. 950912-80-8. Pack Sizes: 25 mg. Product ID: B0084-272284. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PF-8380 | PF-8380 blocks inflammation-induced LPA synthesis. PF-8380 works both in vitro and in vivo through direct inhibition of autotaxin. In human whole blood PF-8380 inhibited autotaxin with an IC50 of 101 nM. Inhibition of ATX by PF-8380 led to decreased invasion and enhanced radiosensitization of GBM cells. Radiation-induced activation of Akt was abrogated by inhibition of ATX. Furthermore, inhibition of ATX led to diminished tumor vascularity and delayed tumor growth. PF-8380 can serve as a tool compound for elucidating LPA's role in inflammation. Group: Pharmaceutical. CAS No. 1144035-53-9. Pack Sizes: 100 mg. Product ID: B2693-457060. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PFI-3 | PFI-3, a potent and selective SMARCA2/4 bromodomain inhibitor, is a cell-permeable probe that binds avidly to the structurally-similar SMARCA4 bromodomain (Kd= 89 nM) and PB1(bromodomain 5) (Kd= 48 nM). Group: Pharmaceutical. CAS No. 1819363-80-8. Pack Sizes: 100 mg. Product ID: B0084-475467. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PFK15 | PFK15 is a potent and selective inhibitor of 6-phosphofructo-2-kinase (PFKFB3) with IC50 of 207 nM. Overexpression of the PFKFB3 enzyme leads to high glycolytic metabolism, which is required for cancer cells to survive in the harsh tumor microenvironment. Group: Pharmaceutical. CAS No. 4382-63-2. Pack Sizes: 250 mg. Product ID: B2693-463353. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pharacine | Pharacine, isolated from the bacterial strain Cytophaga sp. AM13.1, is the first cyclic terephthalic acid ester from a natural source. Group: Pharmaceutical. CAS No. 63440-93-7. Pack Sizes: 10 mg. Product ID: BBF-04419. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pharacine Impurities | Pharacine Impurities play a crucial role in the quality control and analysis of Pharacine, an antibiotic. Identifying and understanding these impurities is essential for ensuring drug efficacy and safety, aiding in regulatory compliance, and optimizing therapeutic outcomes for infections treated with Pharacine. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (-)-Phaseic acid | Phaseic acid is a terpenoid catabolite of abscisic acid. Group: Pharmaceutical. CAS No. 24394-14-7. Pack Sizes: 5 mg. Product ID: B1370-404693. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phaseollidin | Phaseollidin, also called 3,9-Dihydroxy-10-prenylpterocarpan, is a natural flavonoid isolated from the fruits of Phaseolus vulgaris. Phaseollidin exhibits the activity of antimicrobial. Uses: Anti-microbial. Group: Pharmaceutical. CAS No. 37831-70-2. Pack Sizes: 1 mg. Product ID: NP4568. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phaseollin | Phaseollin is a phenolic compound found in theherbs of Erythrina addisoniae. Phaseollin shows anticarcinogenic activity which may lead to new pharmacons to be used in cancer therapy. Uses: Anticarcinogenic. Group: Pharmaceutical. CAS No. 13401-40-6. Pack Sizes: 5 mg. Product ID: NP4639. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phellodendrine | Phellodendrine was effective in crescentic-type anti-GBM nephritis and the antinephritic mechanisms of this agent may be due to its ability to inhibit the proliferation or the migration of macrophages and cytotoxic T lymphocytes in the glomeruli. Uses: Anti-inflammatory. Group: Pharmaceutical. CAS No. 6873-13-8. Pack Sizes: 5 mg. Product ID: NP0563. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phellodendrine chloride | Phellodendrine chloride can be found in the peel of Phellodendron amurense Rupr. Phellodendrine was effective in crescentic-type anti-GBM nephritis and the antinephritic mechanisms of this agent may be due to its ability to inhibit the proliferation or the migration of macrophages and cytotoxic T lymphocytes in the glomeruli. Uses: Hypoglycemic/anti-virus. Group: Pharmaceutical. CAS No. 104112-82-5. Pack Sizes: 20 mg. Product ID: B2703-464407. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phellopterin | Phellopterin is a natural coumarin compound found from Amyris pinnata, Phellopterus littoralis and Ferula alliacea ects. Group: Pharmaceutical. CAS No. 2543-94-4. Pack Sizes: 10 mg. Product ID: NP1100. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenanthrene Impurities | Phenanthrene Impurities, as critical investigative entities, are harnessed within biomedical research to dissect environmental carcinogenic phenomena, elucidating cancer progression. These compounds are vital for decoding drug metabolism intricacies and toxicity, fostering advancements in safer pharmacological formulations and therapeutic strategies aimed at disrupting carcinogenic pathways. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenethylamine Impurities | Phenethylamine Impurities play a crucial role in drug development processes, particularly in ensuring the purity and efficacy of psychoactive medications. They are essential in the study of diseases related to neurological functions, showing potential in aiding the development of treatments for conditions like depression, ADHD, and neurodegenerative disorders. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenformin Hcl Impurities | Phenformin Hcl Impurities, integral to quality assurance, are indispensable in the phenformin manufacturing process, particularly as it pertains to type 2 diabetes treatment. The vigilance in monitoring these impurities is crucial for guaranteeing the therapeutic safety and efficacy, alongside adherence to stringent pharmacological standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenindamine Nitrate Impurities | Phenindamine Nitrate Impurities are vital in pharmaceutical research for ensuring the purity and safety of phenindamine-based medications, primarily utilized for allergy treatment. Identifying and analyzing these impurities contribute to drug formulation accuracy, revealing insights into potential side effects and enhancing drug efficacy for treating allergic reactions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenindione Impurities | Phenindione Impurities occupy a critical role in the rigorous assessment and quality assurance of phenindione, a vital anticoagulant deployed against venous thrombosis and pulmonary embolism. These impurities serve to affirm phenindione's safety and efficacy through meticulous analytical examinations and validation methodologies within the pharmaceutical sector. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pheniramine Impurities | Pheniramine Impurities, trace substances stemming from pheniramine synthesis, are pivotal in ensuring drug safety and efficacy. Primarily used in quality control, these impurities aid in the development of improved antihistamine therapies for allergy relief, ensuring the pharmaceutical product's purity and minimizing potential side effects. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenol, 4,4',4''-ethylidynetris[2,6-bis(methoxymethyl)- | Phenol, 4,4',4''-ethylidynetris[2,6-bis(methoxymethyl)-. Group: Pharmaceutical. CAS No. 672926-26-0. Pack Sizes: 10 g. Product ID: BB076988. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenothiazine Impurities | Phenothiazine Impurities play a crucial role in the pharmaceutical industry by aiding in the synthesis and quality control of antipsychotic drugs. These impurities help researchers understand the stability and efficacy of medications used to treat schizophrenia and bipolar disorder, ensuring safe and effective therapeutic outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenothrin Impurities | Phenothrin Impurities are vital compounds evaluated in pharmacokinetics and toxicology studies to ensure the safety and efficacy of phenothrin-based insecticides. These impurities are analyzed for their potential impact on the health effects associated with phenothrin in biomedical research, especially concerning neurotoxicity and dermatological reactions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenoxazine | Phenoxazine. Group: Pharmaceutical. CAS No. 135-67-1. Pack Sizes: 100 g. Product ID: BB054424. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenprocoumon Impurities | Phenprocoumon Impurities hold considerable importance in the realm of pharmaceuticals, underpinning the safety and efficacy of anticoagulant therapies, especially for thromboembolic conditions. Through meticulous characterization and quantification, they are indispensable in quality control processes, enhancing the production integrity of phenprocoumon, a prevalent vitamin K antagonist. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| phensuximide | Phensuximide is an anticonvulsant drug. It can be used for the treatment of neurological disorders stemming from the brain. Phensuximide can suppress the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of consciousness in petit mal seizures. Uses: Anticonvulsant. Group: Pharmaceutical. CAS No. 86-34-0. Pack Sizes: 50 mg. Product ID: B0084-078550. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phentolamine Impurities | Phentolamine Impurities are compounds studied within the pharmaceutical industry to enhance the safety and efficacy profiles of phentolamine drugs. These impurities are crucial for understanding the metabolic pathways and potential side effects when treating conditions like pheochromocytoma, erectile dysfunction, and hypertension, ensuring safer therapeutic applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phentolamine Mesylate | Phentolamine Mesylate is a nonselective alpha-adrenergic antagonist with IC50 of 0.1 μM. Uses: Adrenergic alpha-antagonists. Group: Pharmaceutical. CAS No. 65-28-1. Pack Sizes: 5 g. Product ID: B0084-074518. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| phenyl(1h-pyrrol-2-yl)methanone | Phenyl(1H-pyrrol-2-yl)methanone, a chemical entity utilized in the biomedicine domain as an intermediary in the preparation of drugs, exhibits promising anti-tumor properties and is being studied intensively for its potential in tackling diverse types of cancers. Its multifaceted therapeutic capabilities entail a comprehensive investigation aimed at establishing its clinical effectiveness. Group: Pharmaceutical. CAS No. 7697-46-3. Pack Sizes: 25 g. Product ID: B2699-076873. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenyl 2,3,4,6-tetra-O-acetyl-a-D-glucopyranoside | Phenyl 2,3,4,6-tetra-O-acetyl-a-D-glucopyranoside is an essential biochemical reagent involved in the synthesis of glycosides and glycosidase inhibitors with potential anti-cancer properties. Leveraging it as a substrate for enzyme assays makes it a valuable addition to research experiments. Caution must be exercised as it is not intended for human consumption and requires careful handling. The multifaceted nature of this product showcases a complex interplay of chemical functionalities, which in turn further reinforces its importance as a key biochemical reagent. Group: Pharmaceutical. CAS No. 3427-45-0. Pack Sizes: 1 g. Product ID: B2705-405005. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenyl 2-hydroxy-4,5-dimethoxybenzoate | Phenyl 2-hydroxy-4,5-dimethoxybenzoate is an impurity of Acotiamide, a drug for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. Group: Pharmaceutical. CAS No. 877997-98-3. Pack Sizes: 1 g. Product ID: B0228-086059. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenyl 3,4,6-Tri-O-acetyl-2-deoxy-1-thio-2-(2,2,2-trichloroethoxyformamido)-b-D-glucopyranoside | Phenyl 3,4,6-Tri-O-acetyl-2-deoxy-1-thio-2-(2,2,2-trichloroethoxyformamido)-b-D-glucopyranoside, an intricate chemical entity, is extensively employed in the realm of biomedical research. Its utilization spans diverse applications embracing the examination of pharmaceutical interplays and the formulation of remedies for numerous ailments. The compound possesses distinctive characteristics and exhibits intricate phenomena, thereby enabling comprehensive inquiries into drug metabolism, protein binding, and receptor interactions. Group: Pharmaceutical. CAS No. 187022-49-7. Pack Sizes: 5 g. Product ID: B2705-286663. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenyl 4-O-acetyl-2,6-Di-O-benzoyl-1-thio-beta-thio-beta-D-galactopyranoside | Phenyl 4-O-acetyl-2,6-Di-O-benzoyl-1-thio-beta-thio-beta-D-galactopyranoside is a compound, exhibiting its paramount significance in delving deep into the enigmatic realms of glycosylation processes and the enthralling world of carbohydrate chemistry. It effortlessly assumes the dual roles of an eminent substrate in an immense array of biochemical assays, particularly those centered around the captivating realms of glycosyltransferases, glycosidases and various other riveting carbohydrate enzymes. Group: Pharmaceutical. CAS No. 152488-28-3. Pack Sizes: 1 g. Product ID: B1370-204821. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenylacetylglutamine Impurities | Phenylacetylglutamine Impurities, often investigated in biomedical research, play a crucial role in understanding metabolic disorders and disease pathology. These impurities can be markers in the study of diseases like phenylketonuria, metabolic syndromes, and certain renal conditions, assisting in the development of diagnostic techniques and therapeutic interventions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenylbutazone Impurities | Phenylbutazone Impurities are vital in the quality control of pharmaceuticals, particularly for the nonsteroidal anti-inflammatory drug phenylbutazone. These impurities monitor and ensure drug purity, efficacy in treating conditions like arthritis, and reduce potential adverse effects, contributing significantly to the safety and effectiveness of anti-inflammatory therapies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenylephrine Impurities | Phenylephrine Impurities, crucial elements in pharmaceutical quality assurance, underpin the meticulous evaluation of phenylephrine's purity and stability profiles. Essential for safeguarding drug safety and therapeutic potency, they play a vital role in nasal congestion alleviation, hypotension management, and mydriasis induction, thereby ensuring robust clinical efficacy across therapeutic applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenylethanolamine A-[d3] | Phenylethanolamine A-[d3] is a labelled Phenylethanolamine A, which is a beta agonist. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: BLP-009139. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenylhydrazine Impurities | Phenylhydrazine Impurities are crucial in the pharmaceutical industry for studying drug stability and safety. These impurities are primarily linked to the development of treatments for diseases like hypertension and certain cancers, ensuring the drugs' efficacy and minimizing adverse effects. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenyl methylcarbamate | Phenyl methylcarbamate can be used as a biomarker of colorectal cancer. It also used as an insecticide. Group: Pharmaceutical. CAS No. 1943-79-9. Pack Sizes: 5 g. Product ID: B0001-085445. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phenytoin Impurities | Phenytoin Impurities are crucial in the quality control and safety assessment of phenytoin, an antiepileptic medication. These impurities provide insights into degradation pathways and stability, ensuring the therapeutic efficacy of phenytoin in managing conditions like epilepsy and seizure disorders. Understanding these impurities helps optimize drug formulation and regulatory compliance. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phlogacantholide B | Phlogacantholide B is extracted from the roots of Phlogacanthus curviflorus. Group: Pharmaceutical. CAS No. 830347-16-5. Pack Sizes: 5 mg. Product ID: NP1668. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phloretin | Phloretin, a type of natural phenol found in the peels of apples, is a dihydrochalcone that shows beneficial effects on diabetes. Phloretin has whitening, freckle removal, anti-aging, strong antioxidant, and photoprotective effects. It can also inhibit the activity of matrix metalloproteinase (MMP-1) and elastase, which can degrade skin connective tissue and play an important role in the process of skin photoaging. Phloretin has excellent immunosuppressive and anti-inflammatory effects. Phloretin can significantly inhibit the levels of nitrogen oxide, prostaglandin E2, IL-6, TNF-α, iNOS and COX-2, inhibit the nuclear translocation of NF-JB subunit p65 protein, and reduce phosphorylation in the MAPK pathway. It can be used in facial masks, skin creams, lotions and essences. Uses: Antimicrobial activity. Group: Pharmaceutical. CAS No. 60-82-2. Pack Sizes: 100 g. Product ID: NP0981. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phlorizin | Phlorizin is a 2'-glucoside of phloretin. It belongs to the group of dihydrochalcones, a type of flavonoids. Phlorizin is found in the herbs of Prunus armeniaca L. Phlorizin has many important biological activities such as lowering blood sugar, improving memory, anti-oxidation, anti-cancer, etc., and has a wide range of application prospects in the development of new drugs and natural health foods. Uses: Peroxynitrite scavenging/antifeedant. Group: Pharmaceutical. CAS No. 60-81-1. Pack Sizes: 100 g. Product ID: NP0932. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phloroglucinol Impurities | Phloroglucinol Impurities are essential analytical tools in the biomedical sector, primarily used in the quality control and development of Phloroglucinol-based medications. These impurities help identify and quantify Phloroglucinol's presence in formulations, ensuring efficacy and safety in drugs targeting gastrointestinal disorders, including irritable bowel syndrome and biliary colics. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PHM-27 (human) | PHM-27 (human) is an endogenous peptide analog of human prepro-VIP and potent agonist for the human calcitonin receptor. Group: Pharmaceutical. CAS No. 87403-73-4. Pack Sizes: 1 mg. Product ID: BAT-006086. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phosphate Impurities | Phosphate Impurities are critical analytes in drug formulation and synthesis. Monitoring their levels is essential for ensuring drug purity and efficacy, particularly in treatments for diseases such as osteoporosis and chronic kidney disease, where phosphate balance is crucial for patient outcomes and therapeutic effectiveness. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phospho(enol)pyruvic acid tri(cyclohexylammonium) salt | The chemical compound, Phospho(enol)pyruvic acid tri(cyclohexylammonium) salt, is a complex and multifaceted substance extensively utilized in the biomedical field for investigating ailments related to glycolysis, such as cancer and diabetes. Additionally, this compound acts as a pivotal substrate for enzymes, enabling the detection and diagnosis of these conditions. Group: Pharmaceutical. CAS No. 35556-70-8. Pack Sizes: 1 g. Product ID: B2699-188833. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phosphonic acid, [(1S)-1-hydroxyethyl]-, dimethyl ester | Dimethyl ester of [(1S)-1-hydroxyethyl]-phosphonic acid is an intriguing derivative of phosphonic acid that has been analyzed extensively due to its potential as an anti-osteoporotic drug as well as its application as a chelating agent for heavy metal ions and a flame retardant for polymers. Its multifaceted usage makes it an attractive compound for further research and development. Group: Pharmaceutical. CAS No. 106692-44-8. Pack Sizes: 5 g. Product ID: B2699-055034. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phosphonic acid, (2-ethylhexyl)-, mono(2-ethylhexyl) ester | (2-Ethylhexyl) diphenyl phosphate, an esteemed biomedical commodity, boasts of its versatility in the medical industry as a plasticizing agent employed in medical apparatuses, notably PVC tubing and blood bags, while also exhibiting efficacy in ameliorating a myriad of neurological illnesses, particularly Alzheimer's disease, thanks to its calcium modulating properties within the brain. Group: Pharmaceutical. CAS No. 14802-03-0. Pack Sizes: 100 g. Product ID: B1370-166970. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Phosphonosuccinic acid | Phosphonosuccinic acid is a useful research chemical. Group: Pharmaceutical. CAS No. 5768-48-9. Pack Sizes: 1 g. Product ID: B1370-255375. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.